CELLECT BIOTECHNOLOGY LTD (APOP)
Institutional ownership reported to the SEC as of Q3 2021, across 5 quarters.
5
Reporting holders
$937.0K
Reported value
0.0%
Held as options
-3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $670.0K | 36,291 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $240.0K | 13,003 | 0.00% | new | NEW |
| MORGAN STANLEY | $22.0K | 1,213 | 0.00% | new | NEW |
| JPMORGAN CHASE & CO | $3.0K | 177 | 0.00% | new | NEW |
| HUNTINGTON NATIONAL BANK | $2.0K | 125 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2021 | 5 | $937.0K | 50,809 | 5 | 0 | 0 | 0.0% |
| Q3 2019 | 8 | $345.0K | 712,944 | 1 | 2 | 4 | 0.0% |
| Q2 2019 | 9 | $562.0K | 1,103,385 | 2 | 5 | 0 | 0.0% |
| Q1 2019 | 10 | $573.0K | 567,879 | 4 | 3 | 0 | 0.0% |
| Q4 2018 | 7 | $294.0K | 139,702 | 1 | 0 | 0 | 0.0% |